Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Carcinoma 1

Interventions

Exercise 59 Radiotherapy 49 Blood Specimen Collection 45 Radiosurgery 37 Drug Therapy 35 Standard of Care 32 Surgical Procedures, Operative 30 Magnetic Resonance Spectroscopy 26 Laparoscopy 24 Cisplatin 24 Cyclophosphamide 23 Control Groups 23 Biopsy 23 Acupuncture Therapy 23 Magnetic Resonance Imaging 20 Saline Solution 19 Radiofrequency Ablation 19 Endoscopic Mucosal Resection 19 camrelizumab 16 Surveys and Questionnaires 16 Propofol 16 Metformin 16 Cytarabine 16 anlotinib 15 Preoperative Exercise 15 Injections 15 Fluorouracil 15 Radiotherapy, Intensity-Modulated 14 Neoadjuvant Therapy 14 Early Intervention, Educational 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Unknown × zimberelimab × Clear all

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Gastrointestinal

Biliary Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡